Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Clinical significance of oxidation and acetylation genetic polymorphism in patients with Parkinson's disease].

Neurologia i neurochirurgia polska - 1 Jan 2000

Milejski P, Orzechowska-Juzwenko K, Kamienowski J, Horoch E, Niewiński P, Hurkacz M, Rzemisławska Z

Abstract excerpt

The relationship between genetically determined polymorphic oxidation and acetylation and susceptibility to some disease has aroused much interest. The aim of our study was to evaluate whether patients with Parkinson's disease differ from healthy persons in their ability to oxidize sparteine and acetylate sulfadimidine as model drugs. Oxidation and acetylation phenotypes were estimated in 50 patients with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acetylation
Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Anti-Infective Agents

Share to Oxidation-Reduction

Share to Parkinson Disease

Share to Polymorphism, Genetic

Share to Sparteine

Share to Sulfamethazine

Source

Identifiers

PMID: 10672554

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Clinical significance of oxidation and acetylation genetic polymorphism in patients with Parkinson's disease].PMID 10672554Read ↗

[Phenotypes of oxidation and acetylation in Alzheimer's disease--preliminary report].Semantic proximity Read ↗

[Clinical significance of the determination of oxidation and acetylation phenotype in patients with multiple sclerosis].Semantic proximity Read ↗

[The role of N-acetyltransferase polymorphism in the pathogenesis of Parkinson's disease].Semantic proximity Read ↗

[Clinical significance of oxidation and acetylation genetic polymorphism in patients with hyperthyreosis].Semantic proximity Read ↗

N-acetyltransferase 2 polymorphism in sporadic Parkinson's disease in a Polish population.Semantic proximity Read ↗

N-acetyltransferase-2 polymorphism in Parkinson's disease: the Rotterdam study.Semantic proximity Read ↗

Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease.Semantic proximity Read ↗

Association of N-acetyl transferase 2 gene polymorphism and slow acetylator phenotype with young onset and late onset Parkinson's disease among Indians.Semantic proximity Read ↗

Xenobiotic metabolism in idiopathic Parkinson's disease in Nigerian Africans.Semantic proximity Read ↗

Slow allotypic variants of the NAT2 gene and susceptibility to early-onset Parkinson's disease.Semantic proximity Read ↗

Prediction of phenotype for acetylation and for debrisoquine hydroxylation by DNA-tests in healthy human volunteers.Semantic proximity Read ↗

Effect of ALDH2 on Sleep Disturbances in Patients with Parkinson's Disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.